Genome-wide association for smoking cessation success: Participants in a trial with adjunctive denicotinized cigarettes

Tomas Drgon, Catherine Johnson, Donna Walther, Anthony P. Albino, Jed E. Rose, George R. Uhl

Research output: Contribution to journalArticle

Abstract

The ability to quit smoking successfully displays substantial heritability in classical and molecular genetic studies. Twin studies suggest that some of the genetics for the ability to quit overlap with genetic components of nicotine dependence, but many do not. Genome-wide association (GWA) studies have demonstrated haplotypes that distinguish successful quitters from individuals who were not able to quit smoking in: i) clinical trials that employed nicotine replacement; ii) clinical trials that employed bupropion; and iii) community quitter samples.We now report novel GWA results from participants in a clinical trial that document the efficacy of adjunctive use of denicotinized cigarettes. These results buttress data from our prior GWA studies of smoking cessation. They suggest that ability to change smoking behavior using denicotinized cigarettes shares substantial underlying genetics with the ability to change this behavior in community settings or in response to treatments with nicotine replacement or bupropion.

Original languageEnglish (US)
Pages (from-to)268-274
Number of pages7
JournalMolecular Medicine
Volume15
Issue number7-8
DOIs
StatePublished - Jul 2009

Fingerprint

Aptitude
Smoking Cessation
Tobacco Products
Genome
Bupropion
Genome-Wide Association Study
Smoking
Clinical Trials
Nicotine
Tobacco Use Disorder
Twin Studies
Haplotypes
Molecular Biology

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)

Cite this

Genome-wide association for smoking cessation success : Participants in a trial with adjunctive denicotinized cigarettes. / Drgon, Tomas; Johnson, Catherine; Walther, Donna; Albino, Anthony P.; Rose, Jed E.; Uhl, George R.

In: Molecular Medicine, Vol. 15, No. 7-8, 07.2009, p. 268-274.

Research output: Contribution to journalArticle

Drgon, Tomas ; Johnson, Catherine ; Walther, Donna ; Albino, Anthony P. ; Rose, Jed E. ; Uhl, George R. / Genome-wide association for smoking cessation success : Participants in a trial with adjunctive denicotinized cigarettes. In: Molecular Medicine. 2009 ; Vol. 15, No. 7-8. pp. 268-274.
@article{594bdded317744fc89c18688d2ffe0b2,
title = "Genome-wide association for smoking cessation success: Participants in a trial with adjunctive denicotinized cigarettes",
abstract = "The ability to quit smoking successfully displays substantial heritability in classical and molecular genetic studies. Twin studies suggest that some of the genetics for the ability to quit overlap with genetic components of nicotine dependence, but many do not. Genome-wide association (GWA) studies have demonstrated haplotypes that distinguish successful quitters from individuals who were not able to quit smoking in: i) clinical trials that employed nicotine replacement; ii) clinical trials that employed bupropion; and iii) community quitter samples.We now report novel GWA results from participants in a clinical trial that document the efficacy of adjunctive use of denicotinized cigarettes. These results buttress data from our prior GWA studies of smoking cessation. They suggest that ability to change smoking behavior using denicotinized cigarettes shares substantial underlying genetics with the ability to change this behavior in community settings or in response to treatments with nicotine replacement or bupropion.",
author = "Tomas Drgon and Catherine Johnson and Donna Walther and Albino, {Anthony P.} and Rose, {Jed E.} and Uhl, {George R.}",
year = "2009",
month = "7",
doi = "10.2119/molmed.2009.00040",
language = "English (US)",
volume = "15",
pages = "268--274",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "7-8",

}

TY - JOUR

T1 - Genome-wide association for smoking cessation success

T2 - Participants in a trial with adjunctive denicotinized cigarettes

AU - Drgon, Tomas

AU - Johnson, Catherine

AU - Walther, Donna

AU - Albino, Anthony P.

AU - Rose, Jed E.

AU - Uhl, George R.

PY - 2009/7

Y1 - 2009/7

N2 - The ability to quit smoking successfully displays substantial heritability in classical and molecular genetic studies. Twin studies suggest that some of the genetics for the ability to quit overlap with genetic components of nicotine dependence, but many do not. Genome-wide association (GWA) studies have demonstrated haplotypes that distinguish successful quitters from individuals who were not able to quit smoking in: i) clinical trials that employed nicotine replacement; ii) clinical trials that employed bupropion; and iii) community quitter samples.We now report novel GWA results from participants in a clinical trial that document the efficacy of adjunctive use of denicotinized cigarettes. These results buttress data from our prior GWA studies of smoking cessation. They suggest that ability to change smoking behavior using denicotinized cigarettes shares substantial underlying genetics with the ability to change this behavior in community settings or in response to treatments with nicotine replacement or bupropion.

AB - The ability to quit smoking successfully displays substantial heritability in classical and molecular genetic studies. Twin studies suggest that some of the genetics for the ability to quit overlap with genetic components of nicotine dependence, but many do not. Genome-wide association (GWA) studies have demonstrated haplotypes that distinguish successful quitters from individuals who were not able to quit smoking in: i) clinical trials that employed nicotine replacement; ii) clinical trials that employed bupropion; and iii) community quitter samples.We now report novel GWA results from participants in a clinical trial that document the efficacy of adjunctive use of denicotinized cigarettes. These results buttress data from our prior GWA studies of smoking cessation. They suggest that ability to change smoking behavior using denicotinized cigarettes shares substantial underlying genetics with the ability to change this behavior in community settings or in response to treatments with nicotine replacement or bupropion.

UR - http://www.scopus.com/inward/record.url?scp=67650469083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650469083&partnerID=8YFLogxK

U2 - 10.2119/molmed.2009.00040

DO - 10.2119/molmed.2009.00040

M3 - Article

C2 - 19593411

AN - SCOPUS:67650469083

VL - 15

SP - 268

EP - 274

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 7-8

ER -